
-
2001
Company Description
Intrapace develops a novel implantable system to treat obesity.
IntraPace has developed a novel implantable system to treat obesity. It is built on the proven technology used in millions of cardiac pacemakers and defibrillators each year. The abiliti system is designed to be implanted via standard laparoscopic instruments without making any changes to the anatomy of the digestive system or placing any limitations on what a person can eat or drink.
-
Manufacturer:
Science and Engineering -
Formed:
2001 -
Company Website:
-
Company E-mail:
-
Company Address:
2051 Ringwood Ave.San Jose, CAUnited States -
CEO:
- Chris Rowland
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits